文献速递糖尿病肥胖与代谢综合征

2型糖尿病进食障碍高发及其与心血管和死亡风险的关联

High incidence of eating disorders in individuals with type 2 diabetes and their association with cardiovascular and mortality risks.
PubMed 文献 · Diabetologia · 2025-11-26

这项全国性回顾性队列研究纳入2013至2014年接受健康检查的1896493名20岁以上成年人,评估2型糖尿病患者的进食障碍发生率及其对全因死亡、复合心血管病、心血管相关死亡和住院的影响。结果显示2型糖尿病组进食障碍发生率升高(aHR 1.20),合并进食障碍者全因死亡、复合心血管病、心血管相关死亡和住院风险均显著增加。

要点

  • 2型糖尿病患者进食障碍发生率高于一般人群(aHR 1.20)。
  • 使用胰岛素者进食障碍发生率更高(aHR 1.30)。
  • 合并进食障碍的2型糖尿病患者全因死亡和心血管风险显著增加。

核心结论

  • 2型糖尿病合并进食障碍增加全因死亡、复合心血管病、心血管相关死亡和心血管相关住院风险。
  • 2型糖尿病使用胰岛素者进食障碍发生率高于非使用者,早期诊断和个体化干预对改善结局至关重要。

研究设计与样本

  • 全国性回顾性队列研究,纳入2013至2014年接受健康检查的1896493名20岁以上成年人。
  • 采用时变Cox分析评估进食障碍对2型糖尿病患者全因死亡、复合心血管病、心血管相关死亡和住院的影响。

主要发现

  • 2型糖尿病组进食障碍发生率高于一般人群(aHR 1.20 [95% CI 1.12, 1.28])。
  • 胰岛素使用者进食障碍发生率aHR 1.30 [1.09, 1.54],非胰岛素使用者aHR 1.18 [1.11, 1.27]。
  • 2型糖尿病合并进食障碍组全因死亡aHR 2.57 [2.30, 2.87],复合心血管病aHR 1.68 [1.44, 1.96]。
  • 心血管相关死亡aHR 2.68 [1.94, 3.70],心血管相关住院aHR 1.61 [1.37, 1.89]。

临床怎么用

  • 对2型糖尿病患者,尤其胰岛素使用者,应关注进食障碍的早期识别和个体化干预。
  • 合并进食障碍的2型糖尿病患者需加强心血管风险和死亡风险管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: We examined the incidence of eating disorders (ED) in individuals with type 2 diabetes and their impact on all-cause mortality, composite CVD, cardiovascular (CV)-related mortality and CV-related hospitalisation. METHODS: This nationwide retrospective cohort study included 1,896,493 adults aged 20 years or older who underwent health examinations between 2013 and 2014. Time-varying Cox analyses were used to evaluate the effects of ED on all-cause mortality, composite CVD, CV-related mortality and CV-related hospitalisation in individuals with type 2 diabetes. RESULTS: The type 2 diabetes group demonstrated an increased incidence of ED (adjusted HR [aHR] 1.20 [95% CI 1.12, 1.28]) compared with the general population. Furthermore, the incidence of ED was higher among insulin users (aHR 1.30 [1.09, 1.54]) than among non-insulin users (aHR 1.18 [1.11, 1.27]). The type 2 diabetes with ED group showed an increased rate of all-cause mortality (aHR 2.57 [2.30, 2.87]), composite CVD (aHR 1.68 [1.44, 1.96]), CV-related mortality (aHR 2.68 [1.94, 3.70]), and CV-related hospitalisation (aHR 1.61 [1.37, 1.89]). CONCLUSIONS/INTERPRETATION: Type 2 diabetes mellitus and ED increased all-cause mortality, composite CVD, CV-related mortality and CV-related hospitalisation. ED incidence was higher among insulin users with type 2 diabetes. Therefore, early diagnosis and personalised interventions are crucial to improve outcomes in this high-risk population.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Cho SH, Kim S, Oh R, et al. High incidence of eating disorders in individuals with type 2 diabetes and their association with cardiovascular and mortality risks. Diabetologia. 2025. PMID: 41296037. doi:10.1007/s00125-025-06615-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。